MetLife, Inc. $MET Shares Acquired by Korea Investment CORP

Korea Investment CORP lifted its stake in MetLife, Inc. (NYSE:MET) by 12.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 666,354 shares of the financial services provider’s stock after purchasing an additional 71,781 shares during the period. Korea Investment CORP owned about 0.10% of MetLife worth $54,888,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Grantham Mayo Van Otterloo & Co. LLC grew its position in shares of MetLife by 154.8% during the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 74,806 shares of the financial services provider’s stock worth $6,162,000 after buying an additional 45,447 shares in the last quarter. Ameriflex Group Inc. raised its holdings in MetLife by 103.1% in the third quarter. Ameriflex Group Inc. now owns 2,504 shares of the financial services provider’s stock valued at $206,000 after acquiring an additional 1,271 shares in the last quarter. Angeles Wealth Management LLC purchased a new position in MetLife in the third quarter worth approximately $212,000. First Trust Advisors LP grew its holdings in MetLife by 173.4% during the 3rd quarter. First Trust Advisors LP now owns 1,641,253 shares of the financial services provider’s stock worth $135,190,000 after acquiring an additional 1,040,894 shares in the last quarter. Finally, HUB Investment Partners LLC grew its holdings in MetLife by 4.7% during the 3rd quarter. HUB Investment Partners LLC now owns 4,736 shares of the financial services provider’s stock worth $390,000 after acquiring an additional 214 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife News Summary

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife confirmed its previously announced Q1 2026 dividend on its Series A floating-rate preferred shares, $0.31501229 per share, signaling consistency in capital returns for preferred holders and helping support yield-sensitive investors. Article Title
• Positive Sentiment: MetLife and partner Crow Holdings completed the sale/trade of 210 multifamily units in Tampa — an example of active portfolio management that can free capital or crystallize gains from real-estate holdings. Article Title
• Neutral Sentiment: MetLife GCC leased ~75,000 sq ft in Noida’s Oxygen Business Park — a regional expansion/lease that speaks to business presence in India but is unlikely to move the stock materially in the near term. Article Title
• Neutral Sentiment: High-profile events at MetLife Stadium (temporary renaming/World Cup hosting coverage, ticket guides) increase brand visibility and venue revenue potential, but these items are peripheral to core insurance fundamentals. Article Title
• Neutral Sentiment: A recent piece comparing MetLife’s stock performance to peers provides context for relative valuation and momentum; useful for investors but not a direct catalyst. Article Title
• Negative Sentiment: Morgan Stanley published a pessimistic forecast for MET, which likely contributed to selling pressure and the intraday decline — analyst downgrades/price-target cuts are common drivers of short-term stock weakness. Article Title

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on MET. Keefe, Bruyette & Woods reduced their price objective on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a report on Tuesday, November 11th. Barclays set a $90.00 target price on MetLife in a report on Thursday, January 8th. Evercore set a $95.00 price target on MetLife in a research note on Tuesday, February 10th. UBS Group upped their price objective on MetLife from $94.00 to $98.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Finally, Mizuho set a $100.00 price objective on MetLife in a report on Thursday, February 12th. Two research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $94.18.

MetLife Stock Down 1.5%

MET stock opened at $71.83 on Monday. The company has a market cap of $46.84 billion, a price-to-earnings ratio of 15.28, a price-to-earnings-growth ratio of 0.66 and a beta of 0.76. The company has a fifty day moving average price of $77.20 and a 200 day moving average price of $78.72. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $85.00.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The company had revenue of $52.44 billion for the quarter, compared to the consensus estimate of $31.43 billion. During the same period last year, the firm posted $2.08 EPS. MetLife’s revenue for the quarter was up 27.6% on a year-over-year basis. Sell-side analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd will be given a $0.5675 dividend. This represents a $2.27 annualized dividend and a yield of 3.2%. The ex-dividend date is Tuesday, February 3rd. MetLife’s payout ratio is 48.30%.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.